Influenza B Antigen
Influenza B is only known to infect humans and seals. Influenza infection in humans causes chills, fever, pharyngitis, muscle pain, headaches, coughing and weakness. The virus is transmitted through the air by coughs or sneezes or through saliva, nasal secretions, faeces and blood. Infection may occur through direct contact with infected bodily fluid or contaminated surfaces. Influenza B viruses mutate slower than Influenza A, but fast enough that lasting immunity is not possible. The slower mutation rate and limited host range makes Influenza B less like to cause pandemics than Influenza A.
- Target Species
- Product Form
- Inactivated Influenza B antigen - liquid
- Influenza B, strain Hong Kong 5/72, cultured in MDCK cells. Clarified and concentrated cell culture supernatant. The antigen preparation is inactivated by gamma radiation.
- Buffer Solution
- Eagle's Minimum Essential Medium
- Preservative Stabilisers
- None present
- 20480 HA units/ml as determined by hemagglutination endpoint assay.
This product has been rendered inactive by gamma radiation. However this material should still be handled as infectious and should be disposed of appropriately.
- Approx. Protein Concentrations
- Total protein concentration 1.70 mg/ml
- Store at -70oC.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted.
Avoid repeated freezing and thawing as this may denature the protein.
- 18 months from date of despatch
- For research purposes only
Applications of Influenza B Antigen
|Application Name||Verified||Min Dilution||Max Dilution|
- Instructions For Use
- The preparation might be slightly cloudy or contain minor precipitate upon thawing. Do not sonicate and do not clarify prior to dilution at least 10-fold with working buffer.